Healthcare Marketing Blogs
03|17|26
4th Annual Brand Planning Report: Fueling Brand Plan Success Through AI‑Powered Integration
In our fourth annual report, Chief Strategy Officer at EVERSANA INTOUCH, John Kenny, and Senior Partner of EVERSANA MANAGEMENT CONSULTING, Sean Rapson, explore the state of brand planning with input from pharma marketing executives, uncovering persistent gaps in efficiency, consistency, and the ability to harness data effectively.
03|04|26
Rare Disease in Focus: How Innovation Is Accelerating Access for Patients
The rare disease landscape has long been defined by delay, with families frequently facing 7–10 years before receiving a diagnosis. In recognition of Rare Disease Day, Ann Cave, President, Full-Service Agency, wrote an article for PM360 spotlighting how innovation and human insight are reshaping the rare disease landscape.
03|02|26
Creative That Connects: Earning Trust in Rare Disease Communities
In honor of Rare Disease Day, Patrick Brodfuehrer penned an article in Med Ad News that explores what authentic connection really means for the 300 million people worldwide living with a rare disease.
02|13|26
The “Pharma Bowl”: How Super Bowl 60 Became Pharma’s Biggest Stage
From GLP‑1 dominance to celebrity‑driven disease awareness, Super Bowl 60 marked a tipping point in how healthcare brands show up on the world’s biggest advertising stage. What was once considered a high‑risk investment is now a calculated brand‑building move, signaling a shift in how pharma thinks about cultural relevance, storytelling, and long‑term equity.
01|30|26
Mind + Machine: How 2026 Brands Will Win the Future of Pharma Marketing
In our recent webinar, leaders across strategy, creative, technology and omnichannel disciplines explored one essential question: How do 2026 brands win in a rapidly transforming healthcare ecosystem?
01|09|26
The Omnichannel Renaissance: What’s Next for Pharma in 2026?
The life sciences industry is entering a new era. In a recent article penned for Med Ad News, Dan Gandor, EVP of Omnichannel Strategy, coined this the “Omnichannel Renaissance.”
12|29|25
AI’s Next Big Move: Why Pharma Marketers Should Pay Attention
Artificial intelligence is changing the way people interact online, and the pace of innovation is accelerating. Just a few years ago, generative AI was a novelty. Today, platforms such as ChatGPT have become essential tools for millions, shaping how information is shared and decisions are made. At EVERSANA INTOUCH, we’re closely monitoring the next phase […]
12|22|25
DHC Monthly: What Pharma Marketers Should Act On for 2026
The Digital Health Coalition’s December newsletter spotlights year‑end trends and predictions for 2026, featuring insights 18 industry leaders including Susan Perlbachs and Dan Gandor. Read the blog to learn about their key perspectives for 2026.
12|18|25
Balancing Global Consistency and Local Nuance in Pharma Brand Strategy
Creating a brand that resonates across markets while maintaining a strong global identity is one of pharma’s most persistent challenges. According to Susan Perlbachs and John Kenny solving this tension requires a shift in how marketers generate insight, make decisions and adapt creative to cultural nuance.
12|08|25
Leading Healthcare Marketing Into a New Era: Looking Ahead to 2026
As 2025 closes, EVERSANA INTOUCH leaders were featured in Med Ad News’ annual Healthcare Agency Roundup. They shared their insights on how trends are shaping the industry both today and tomorrow and noted how healthcare marketing is entering a transformative era driven by trust, technology and authenticity. Read the blog to learn more.